Sulfonyl compounds which modulate the CB2 receptor

US8846936B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Eugene Richard Hickey · Danbury, US
• Doris Riether · Biberach an der Riß, DE
• Monika Ermann · Wantage, GB

Key dates

• Filing date: Jul 18, 2011
• Grant date: Sep 30, 2014
• Expiry date: Jul 18, 2031

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula (I) and formula (II) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.